查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1621573

尿液檢查市場：按產品、檢測類型、應用、最終用途 - 2025-2030 年全球預測

Urinalysis Market by Product (Consumables, Instruments), Test Type (Biochemical Urinalysis, Pregnancy & Fertility Tests, Sediment Urinalysis), Application, End-Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年尿液檢查市值為43億美元，預計2024年將達45.3億美元，複合年成長率為5.76%，預計到2030年將達到63.7億美元。

尿液檢查涵蓋範圍廣泛，重點是用於醫學評估和疾病監測的尿液檢查，既作為重要的診斷工具，又作為常規健康檢查方法。這個過程對於早期發現糖尿病、腎臟疾病和尿道感染等疾病至關重要，有助於預防性醫療保健。該應用程式用途廣泛，廣泛應用於不同的人群，包括醫院、診斷實驗室和家庭。尿液檢查的需求源於其非侵入性、易於操作以及提供豐富且重要的健康資訊的能力。根據市場洞察，該行業的成長主要是由慢性病盛行率上升、預防保健意識增強以及診斷方法技術進步所推動的。可攜式、侵入性較小的檢測套組的出現滿足了對家庭監控解決方案不斷成長的需求，並代表了一個巨大的潛在機會。然而，市場限制包括結果可能不準確以及需要使用更複雜的診斷工具進行交叉檢驗，從而增加了使用和解釋的複雜性。此外，嚴格的監管要求和缺乏標準化等挑戰可能會阻礙市場成長。創新領域已經成熟，例如透過人工智慧和機器學習演算法開發更準確和個人化的尿液檢查，以及整合物聯網 (IoT) 連接以增強即時資料監測和病人參與。尿液檢查市場的本質是動態的，在技術和消費者對更容易獲得的健康見解的需求的推動下，穩步轉向以患者為中心的護理。希望利用這些趨勢的公司應該優先進行研究，使尿液檢查更加方便用戶使用和準確，同時需要協調法規以克服障礙並擴大市場範圍。

主要市場統計
基準年[2023] 43億美元
預測年份 [2024] 45.3億美元
預測年份 [2030] 63.7億美元
複合年成長率（%） 5.76%

市場動態：揭示快速發展的尿液檢查市場的關鍵市場洞察

供需的動態交互作用正在改變尿液檢查市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 全球腎臟疾病和尿道感染盛行率不斷上升
    • 政府積極致力於慢性病的早期篩檢和管理
    • 臨床實驗室和醫院擴大採用照護現場(POC) 系統
  • 市場限制因素
    • 產品召回問題
  • 市場機會
    • 腎臟生物標記和 smaRT-LAMP 系統的技術進步
    • 推出用於尿道感染篩檢的自動分析儀
  • 市場挑戰
    • 缺乏定期健康檢查意識，缺乏熟練的化驗技術人員

波特五力：駕馭尿液檢查市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解尿液檢查市場的外部影響

外部宏觀環境因素在塑造尿液檢查市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解尿液檢查市場的競爭狀況

尿液檢查市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣尿液檢查市場供應商績效評估

FPNV定位矩陣是評估尿液檢查市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製尿液檢查市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，尿液檢查市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開發：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、未開發地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球腎臟疾病和尿道感染的盛行率增加
      • 政府優先採取的早期篩檢和管理舉措

慢性疾病

      • 臨床實驗室和醫院擴大採用照護現場尿液檢查系統
    • 抑制因素
      • 對產品召回的嚴重擔憂
    • 機會
      • 腎臟生物標記和 smaRT-LAMP 系統的技術進步
      • 引進自動分析儀進行尿道感染感染篩檢
    • 任務
      • 缺乏定期健康檢查意識，缺乏熟練的檢查人員
  • 市場區隔分析
    • 產品：廣泛使用收集杯，方便、衛生地收集尿液樣本進行醫療診斷
    • 最終用途：擴大用於臨床實驗室，用於各種疾病的篩檢和診斷
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章尿液檢查市場：分產品

  • 消耗品
    • 收集杯
    • 試劑
    • 尿液檢查/試紙
  • 裝置

第7章尿液檢查市場：依檢測類型

  • 尿液檢查
  • 妊娠及不孕症檢測
  • 尿液檢查

第8章尿液檢查市場：依應用分類

  • 糖尿病
  • 高血壓
  • 腎臟疾病
  • 肝臟疾病
  • 尿道感染

第9章尿液檢查市場：依最終用途分類

  • 臨床實驗室
  • 家庭保健
  • 醫院
  • 研究和學術

第10章 北美及南美尿液檢查市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太尿液檢查市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲尿液檢查市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • AixMed 和 CorePlus 合作進行創新尿液分析研究
    • 豐田合成投資 Eurea 推進尿液分析技術
    • Medtronic)採取策略性舉措，透過新創企業解決尿失禁問題
  • 戰略分析和建議

公司名單

  • 77 Elektronika Kft.
  • Abbott Laboratories
  • ACON Laboratories, Inc. by Inverness Medical
  • AdvaCare Pharma
  • Alphatec Scientific EIRL
  • Analyticon Biotechnologies GmbH by BRAIN Biotech AG
  • Anamol Laboratories Pvt. Ltd.
  • ARKRAY, Inc.
  • Beckman Coulter, Inc. by Danaher Corporation
  • Becton, Dickinson, and Company
  • Bio-Rad Laboratories, Inc.
  • Bioway Biotechnology Co., Ltd.
  • Cardinal Health, Inc.
  • Contec Medical Systems Co., Ltd.
  • Dirui Industrial Co., Ltd.
  • EKF DIAGNOSTICS HOLDINGS PLC
  • Erba Group
  • F. Hoffmann-La Roche Ltd.
  • Kova International, Inc. by LGC Limited
  • MACHEREY-NAGEL GmbH & Co. KG
  • Medsource Ozone Biomedicals Pvt. Ltd.
  • Quidel Corporation
  • Randox Laboratories Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens Healthcare GmbH
  • Sweet Cures Nutra
  • Sysmex Corporation
  • Teco Diagnostics
  • Thermo Fisher Scientific Inc.
  • URIT Medical Electronic Group Co., Ltd
  • Woodley Equipment Company Ltd.
Product Code: MRR-034B5003034D

The Urinalysis Market was valued at USD 4.30 billion in 2023, expected to reach USD 4.53 billion in 2024, and is projected to grow at a CAGR of 5.76%, to USD 6.37 billion by 2030.

Urinalysis encompasses a broad scope as both a critical diagnostic tool and a routine health check method, focusing on the examination of urine for medical assessment and disease monitoring. This process is essential for the early detection of diseases such as diabetes, kidney disorders, and urinary tract infections, contributing to preventive healthcare. The application spans across hospitals, diagnostic laboratories, and home-use settings, making it versatile and widely used across various demographics. The necessity of urinalysis stems from its non-invasive nature, ease of execution, and ability to provide a wealth of vital health information. Market insights reveal that the growth of this sector is primarily driven by the rising incidence of chronic diseases, increased awareness about preventive healthcare, and technological advancements in diagnostic methods. The advent of portable and minimally invasive urinalysis testing kits represents significant potential opportunities, catering to increasing demand for home-based monitoring solutions. However, market limitations include the potential for inaccurate results and the need for cross-verification with more sophisticated diagnostic tools, adding layers of complexity to use and interpretation. Furthermore, challenges such as stringent regulatory requirements and a lack of standardization can impede market growth. Areas ripe for innovation include the development of more accurate, personalized urinalysis tests through artificial intelligence and machine learning algorithms, and the integration of Internet of Things (IoT) connectivity to enhance real-time data monitoring and patient engagement. The nature of the urinalysis market is dynamic, with a steady shift towards patient-centric care, driven by technology and consumer demand for more accessible health insights. Companies aiming to capitalize on these trends should prioritize research into making urinalysis more user-friendly and accurate, while also working towards regulatory harmonization to overcome barriers and expand their market reach.

KEY MARKET STATISTICS
Base Year [2023] USD 4.30 billion
Estimated Year [2024] USD 4.53 billion
Forecast Year [2030] USD 6.37 billion
CAGR (%) 5.76%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Urinalysis Market

The Urinalysis Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of kidney diseases and urinary tract infections worldwide
    • Favorable government initiatives for early screening and management of chronic diseases
    • Rising adoption of point-of-care urinalysis systems in clinical laboratories and hospitals
  • Market Restraints
    • Significant concern for product recall
  • Market Opportunities
    • Technological advancement in renal biomarker and smaRT-LAMP system
    • Emergence of automated analyzers for urinary tract infection screening
  • Market Challenges
    • Lack of awareness about routine health checkup and limited skilled laboratory workforce

Porter's Five Forces: A Strategic Tool for Navigating the Urinalysis Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Urinalysis Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Urinalysis Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Urinalysis Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Urinalysis Market

A detailed market share analysis in the Urinalysis Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Urinalysis Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Urinalysis Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Urinalysis Market

A strategic analysis of the Urinalysis Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Urinalysis Market, highlighting leading vendors and their innovative profiles. These include 77 Elektronika Kft., Abbott Laboratories, ACON Laboratories, Inc. by Inverness Medical, AdvaCare Pharma, Alphatec Scientific E.I.R.L., Analyticon Biotechnologies GmbH by BRAIN Biotech AG, Anamol Laboratories Pvt. Ltd., ARKRAY, Inc., Beckman Coulter, Inc. by Danaher Corporation, Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc., Bioway Biotechnology Co., Ltd., Cardinal Health, Inc., Contec Medical Systems Co., Ltd., Dirui Industrial Co., Ltd., EKF DIAGNOSTICS HOLDINGS PLC, Erba Group, F. Hoffmann-La Roche Ltd., Kova International, Inc. by LGC Limited, MACHEREY-NAGEL GmbH & Co. KG, Medsource Ozone Biomedicals Pvt. Ltd., Quidel Corporation, Randox Laboratories Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens Healthcare GmbH, Sweet Cures Nutra, Sysmex Corporation, Teco Diagnostics, Thermo Fisher Scientific Inc., URIT Medical Electronic Group Co., Ltd, and Woodley Equipment Company Ltd..

Market Segmentation & Coverage

This research report categorizes the Urinalysis Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Consumables and Instruments. The Consumables is further studied across Collection Cups, Reagents, and Urine Strips/Dipsticks.
  • Based on Test Type, market is studied across Biochemical Urinalysis, Pregnancy & Fertility Tests, and Sediment Urinalysis.
  • Based on Application, market is studied across Diabetes, Hypertension, Kidney Diseases, Liver Diseases, and Urinary Tract Infections.
  • Based on End-Use, market is studied across Clinical Laboratories, Home Healthcare, Hospitals, and Research & Academics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of kidney diseases and urinary tract infections worldwide
      • 5.1.1.2. Favorable government initiatives for early screening and management of

chronic diseases

      • 5.1.1.3. Rising adoption of point-of-care urinalysis systems in clinical laboratories and hospitals
    • 5.1.2. Restraints
      • 5.1.2.1. Significant concern for product recall
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancement in renal biomarker and smaRT-LAMP system
      • 5.1.3.2. Emergence of automated analyzers for urinary tract infection screening
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of awareness about routine health checkup and limited skilled laboratory workforce
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Extensive use of collection cups for the simple and hygienic collection of urine samples for medical diagnostics
    • 5.2.2. End-Use: Increasing use in clinical laboratories for screening and diagnosing various disorders
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Urinalysis Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
    • 6.2.1. Collection Cups
    • 6.2.2. Reagents
    • 6.2.3. Urine Strips/Dipsticks
  • 6.3. Instruments

7. Urinalysis Market, by Test Type

  • 7.1. Introduction
  • 7.2. Biochemical Urinalysis
  • 7.3. Pregnancy & Fertility Tests
  • 7.4. Sediment Urinalysis

8. Urinalysis Market, by Application

  • 8.1. Introduction
  • 8.2. Diabetes
  • 8.3. Hypertension
  • 8.4. Kidney Diseases
  • 8.5. Liver Diseases
  • 8.6. Urinary Tract Infections

9. Urinalysis Market, by End-Use

  • 9.1. Introduction
  • 9.2. Clinical Laboratories
  • 9.3. Home Healthcare
  • 9.4. Hospitals
  • 9.5. Research & Academics

10. Americas Urinalysis Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Urinalysis Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Urinalysis Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. AixMed and CorePlus Collaborate on Innovative Urine Analysis Research
    • 13.3.2. Toyoda Gosei Invests in Yuurea Inc. for Advancement in Urine Analysis Technology
    • 13.3.3. Medtronic's Strategic Initiative to Address Urinary Incontinence with New Venture
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 77 Elektronika Kft.
  • 2. Abbott Laboratories
  • 3. ACON Laboratories, Inc. by Inverness Medical
  • 4. AdvaCare Pharma
  • 5. Alphatec Scientific E.I.R.L.
  • 6. Analyticon Biotechnologies GmbH by BRAIN Biotech AG
  • 7. Anamol Laboratories Pvt. Ltd.
  • 8. ARKRAY, Inc.
  • 9. Beckman Coulter, Inc. by Danaher Corporation
  • 10. Becton, Dickinson, and Company
  • 11. Bio-Rad Laboratories, Inc.
  • 12. Bioway Biotechnology Co., Ltd.
  • 13. Cardinal Health, Inc.
  • 14. Contec Medical Systems Co., Ltd.
  • 15. Dirui Industrial Co., Ltd.
  • 16. EKF DIAGNOSTICS HOLDINGS PLC
  • 17. Erba Group
  • 18. F. Hoffmann-La Roche Ltd.
  • 19. Kova International, Inc. by LGC Limited
  • 20. MACHEREY-NAGEL GmbH & Co. KG
  • 21. Medsource Ozone Biomedicals Pvt. Ltd.
  • 22. Quidel Corporation
  • 23. Randox Laboratories Ltd.
  • 24. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 25. Siemens Healthcare GmbH
  • 26. Sweet Cures Nutra
  • 27. Sysmex Corporation
  • 28. Teco Diagnostics
  • 29. Thermo Fisher Scientific Inc.
  • 30. URIT Medical Electronic Group Co., Ltd
  • 31. Woodley Equipment Company Ltd.

LIST OF FIGURES

  • FIGURE 1. URINALYSIS MARKET RESEARCH PROCESS
  • FIGURE 2. URINALYSIS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL URINALYSIS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL URINALYSIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL URINALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL URINALYSIS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL URINALYSIS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL URINALYSIS MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL URINALYSIS MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL URINALYSIS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL URINALYSIS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL URINALYSIS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL URINALYSIS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS URINALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS URINALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES URINALYSIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES URINALYSIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC URINALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC URINALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA URINALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA URINALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. URINALYSIS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. URINALYSIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. URINALYSIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL URINALYSIS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL URINALYSIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL URINALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. URINALYSIS MARKET DYNAMICS
  • TABLE 7. GLOBAL URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL URINALYSIS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL URINALYSIS MARKET SIZE, BY COLLECTION CUPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL URINALYSIS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL URINALYSIS MARKET SIZE, BY URINE STRIPS/DIPSTICKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL URINALYSIS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL URINALYSIS MARKET SIZE, BY BIOCHEMICAL URINALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL URINALYSIS MARKET SIZE, BY PREGNANCY & FERTILITY TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL URINALYSIS MARKET SIZE, BY SEDIMENT URINALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL URINALYSIS MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL URINALYSIS MARKET SIZE, BY HYPERTENSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL URINALYSIS MARKET SIZE, BY KIDNEY DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL URINALYSIS MARKET SIZE, BY LIVER DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL URINALYSIS MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL URINALYSIS MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL URINALYSIS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL URINALYSIS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL URINALYSIS MARKET SIZE, BY RESEARCH & ACADEMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS URINALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES URINALYSIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC URINALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA URINALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 238. URINALYSIS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 239. URINALYSIS MARKET, FPNV POSITIONING MATRIX, 2023